Published in Blood Weekly, June 7th, 2007
"Mr. Jimenez brings a highly-accomplished executive background and much sought-after professional credentials to our team," stated HepaLife President and CEO, Mr. Frank Menzler. "I very much look forward to drawing on Javier's expertise as we advance the commercial development of our cell-based technologies, which continue to produce promising outcomes for key applications, including avian influenza vaccine development, in vitro...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2007-06-07)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.